COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND

被引：0
|
作者：
Gibbons, I [1 ]
Davidson, C. [1 ]
Clark-Wright, J. [1 ]
Miller, C. [2 ]
Carroll, S. [1 ]
Costa, M. [3 ]
Bricout, H. [4 ]
Alvarez, F. P. [4 ]
机构：
[1] Sanofi Pasteur, Reading, Rdg, England
[2] Sanofi Pasteur, Church Crookham, Ham, England
[3] Syneos Hlth, London, Lon, England
[4] Sanofi Pasteur, Lyon, France
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN60
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINES FOR CHILDREN
    Yang, M. C.
    Tan, C. H.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A161 - A161
  • [32] Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
    Ruiz-Aragon, Jesus
    Marquez-Pelaez, Sergio
    Gani, Ray
    Alvarez, Piedad
    Guerrero-Luduena, Richard
    [J]. VACCINES, 2022, 10 (02)
  • [33] Modelling the Economic Impact of influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
    Nguyen, Van Hung
    Roy, Bertrand
    [J]. VACCINES, 2022, 10 (08)
  • [34] High-dose trivalent influenza vaccine. Efficacy and effectiveness
    Gil de Miguel, Angel
    Redondo Marguello, Esther
    Diez Domingo, Javier
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (04) : 226 - 239
  • [35] Cost-Effectiveness of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Adult Hemodialysis Patients
    Lee, Bruce Y.
    Stalter, Randy M.
    Bacon, Kristina M.
    Tai, Julie H. Y.
    Bailey, Rachel R.
    Zimmer, Shanta M.
    Wagner, Michael M.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 724 - 732
  • [36] Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model
    Yang, Ming-Chin
    Tan, Elise Chia-Hui
    Su, Jian-Jhih
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (01) : 81 - 89
  • [37] Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
    Cai, Rui
    Gerlier, Laetitia
    Eichner, Martin
    Schwehm, Markus
    Rajaram, Sankarasubramanian
    Mould-Quevedo, Joaquin
    Lamotte, Mark
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 490 - 501
  • [38] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S651 - S651
  • [39] Reply letter to "Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal"
    Hadigal, Sanjay
    Colombo, Laura
    Cook, Joseph
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 933 - 934
  • [40] The economic value of a quadrivalent versus trivalent influenza vaccine
    Lee, Bruce Y.
    Bartsch, Sarah M.
    Willig, Alyssa M.
    [J]. VACCINE, 2012, 30 (52) : 7443 - 7446
12345